Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2

These findings suggest that semaglutide may mitigate cardiomyocyte injury caused by a high-fat diet through regulation of HDLSDSLEP-1 expression. These discoveries are expected to unveil novel molecular mechanisms and provide new targets for clinical treatment.